New study demonstrates that Colombia, compared to OECD countries, falls behind in terms of Access to New Medications

New study demonstrates that Colombia, compared to OECD countries, falls behind in terms of Access to New Medications

Colombian government gives green light to price control of medicines

Colombian government may intervene the price of new medicines that enter the country.

PFIZER is planning to team up with National Cancer Institute

According to an article published by Fierce Biotech, Pfizer is planning to team up with scientists from the National Cancer Institute to work on three of its leading pipeline immunotherapy oncology medicines.